Botulinum Toxin a in the Treatment of Sialorrhea
Authors:
- 1 January 2007
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 41 (1) , 79-85
Abstract
Objective: To review the efficacy and safety of botulinum toxin A (BTX) in the treatment of sialorrhea. Data Sources: A PubMed search and reference list review was performed to find clinical trials on BTX in the treatment of sialorrhea. The search was limited to English-language trials involving human subjects. Articles from 1965 to October 2006 were searched, using key words botulinum, botulinum toxin, Botox, sialorrhea, saliva, salivary gland, and drooling. Study Selection And Data Extraction: Reports of 15 studies were found on BTX in the treatment of sialorrhea in human subjects. Four controlled trials are presented in detail, and 11 uncontrolled studies are summarized. Data Synthesis: One controlled trial found that BTX caused significant reductions in patients' severity and frequency of drooling compared with placebo. Another found significant saliva reductions in the treatment group receiving the highest dose of BTX but found no subjective improvement compared with the placebo group. A third study comparing BTX with placebo found significant improvements in subjective and objective measures of drooling in the treatment group. A fourth controlled trial found significant reductions from baseline levels of drooling after patients received BTX injections. Similar efficacy was found between the BTX and scopolamine treatment groups. Conclusions: Evidence indicates that BTX is a safe and effective treatment for sialorrhea. More research is needed to determine the ideal dose, injection location, and technique of BTX injections.Keywords
This publication has 15 references indexed in Scilit:
- Botulinum Toxin Injections for Children With Excessive DroolingJournal of Child Neurology, 2005
- Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and SialadenitisThe Laryngoscope, 2004
- Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical TrialPediatrics, 2004
- Intraparotid Injection of Botulinum Toxin A as a Treatment to Control Sialorrhea in Children with Cerebral PalsyAmerican Journal of Physical Medicine & Rehabilitation, 2004
- Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s diseaseClinical Neurology and Neurosurgery, 2004
- A randomized trial of botulinum toxin A for treatment of droolingNeurology, 2003
- The Treatment of Drooling by Ultrasound‐Guided Intraglandular Injections of Botulinum Toxin Type A Into the Salivary GlandsThe Laryngoscope, 2003
- Botulinum toxin A as a treatment for excessive drooling in childrenPediatric Neurology, 2002
- Clinical Study of Botulinum‐A Toxin in the Treatment of Sialorrhea in Children With Cerebral PalsyThe Laryngoscope, 2002
- Botulinum toxin A as treatment for drooling saliva in PDNeurology, 2000